Sustained cardiovascular risk factor control is associated with reduced metabolic dysfunction-associated steatotic liver disease risk in SLE
Femoral plaque progression and persistent IgG anti-beta2 glycoprotein I antibody positivity are independently associated with MASLD in SLE, while MASLD risk is halved for each additional CVRF target sustainedly attained.
Authors
- Petros Paul Sfikakis (ORCID: https://orcid.org/0000-0001-5484-2930)
- George Papatheodoridis (ORCID: https://orcid.org/0000-0002-3518-4060)
- Nikolaos Papazoglou
- Maria G. Tektonidou (ORCID: https://orcid.org/0000-0003-2238-0975)
- Elisavet Michailidou
- Vassiliki Poulia
Institutions
- National and Kapodistrian University of Athens (GR)
- Laiko General Hospital of Athens (GR)
Publication Details
- Journal
- Lara D. Veeken
- Published
- 2025-09-09
- DOI
- https://doi.org/10.1093/rheumatology/keaf483
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00